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Highlights 
 Adipokine inflammation plays a role in autoimmunity initiation in the 
thyroid. 
 PAMP׳s provide an adjuvant signal to overcome tolerance in the 
thyroid. 
 •Sex differences in autoimmunity incidence many be due to adipokine 
differences. 
Abstract 
Autoimmune thyroid diseases (AITDs), predominately Graves׳ disease 
and Hashimoto׳s thyroiditis, comprise the most common autoimmune 
diseases in humans. Both have the production of anti-thyroid antibody as an 
important aspect and both are much more prevalent in females, being at least 
10 times more common than in males. Using these two clues, a hypothesis 
for the initiation of thyroid autoimmunity is proposed that helps to make the 
case that the thyroid is one of the most sensitive sites for autoimmunity and 
helps account for the prevalence and the observed sex differences in AITDs 
and associated diseases, such as type 1 diabetes and Latent Autoimmune 
Diabetes in Adults (LADA). 
The primary mechanisms proposed involve the underlying state of 
inflammation as a result of the adipokines, especially leptin, TNF-α, and IL-6, 
and the receptors able to recognize pathogen-associated molecular patterns 
(PAMP׳s) and damage-associated molecular patterns (DAMP׳s) through Toll-
like receptors (TLR) and others receptors present on thyrocytes. The 
adipokines are produced by adipose tissue, but have hormone-like and 
immune modulating properties. As the levels of leptin are significantly higher 
in females, an explanation for the sex difference in thyroid autoimmunity 
emerges. The ability of the thyrocytes to participate in innate immunity 
through the TLR provides an adjuvant-like signal and allows for the action of 
other agents, such as environmental factors, viruses, bacteria, and even 
stress to provide the initiation step to break tolerance to thyroid self-antigens. 
Seeing the thyroid as one of the most sensitive sites for autoimmunity, 
means that for many autoimmune disorders, if autoimmunity is present, it is 
likely to also be present in the thyroid – and that that condition in the thyroid 
was probably earlier. The evidence is seen in multiple autoimmune syndrome. 
Keywords: Leptin, Adipokines, Hashimoto׳s thyroiditis, Graves׳ disease, 
PAMP׳s 
1. Introduction 
The thyroid gland can host two common autoimmune diseases, 
Graves׳ disease and Hashimoto׳s thyroiditis (autoimmune thyroiditis). 
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Graves׳ disease results in hyperthyroidism which has an estimated 
prevalence of 80/100,000/year in women and 8/100,000/year in men 
in Western countries (McGrogan et al., 2008). The primary cause of 
hypothyroidism in the West (where dietary iodine is generally at 
sufficient levels) is Hashimoto׳s disease. Hypothyroidism has an 
estimated incidence of 2.2/100,000/year for men and 
498.4/100,000/year for females in Western countries (McGrogan et 
al., 2008). Taken together, autoimmune thyroid diseases (AITDs) are 
the most common autoimmune diseases in humans (Hayter and Cook, 
2012). 
Autoimmune thyroid disease results from the breaking of 
tolerance to self-antigens of the thyroid. There appears to be several 
ways in which this can happen, including infection, genetic 
predisposition (Medici et al., 2014), environment, some drugs 
including IFN-α (Tomer et al., 2007), and dietary iodine (Hansen et al., 
2006 and Tomer and Huber, 2009). Although the mechanisms of the 
two diseases involve different arms of the immune response for their 
primary destructive result (antibody for Graves׳ and cell-mediated 
immunity for Hashimoto׳s), there are common pivotal anti-thyroid 
antibodies that both serve to characterize the nature of the diseases, 
and to allow monitoring of the disease progression as in other 
autoimmune diseases (Damoiseaux, 2013). As various anti-thyroid 
antibodies need to be generated in both diseases, the nature of their 
targets, and the propensity of aspects of the immune response to 
react through genetics and environmental influences (Burek and 
Taylor, 2009) are clearly involved, although the role of antibody in the 
autoimmune destruction of Hashimoto׳s thyroiditis is not understood. 
Additional avenues to the breaking of tolerance, probably involving 
cross reactivity of antibody due to molecular mimicry, have also been 
suggested. These include responses to Candida albicans ( Vojdani et 
al., 1996), Bifidobacterium and Lactobacillis species ( Kiseleva et al., 
2011), Helicobacter pylori strains expressing CagA ( Figura et al., 
1999), Yersinia enterocolitica ( Guarneri et al., 2011), Clostridium 
botulinum neurotoxin A ( Gregoric et al., 2011), HCV (Tomer and 
Villanueva, 2004), and human parvovirus B19 (Mori et al., 2007). 
Recently Gammazza et al. (2014) have identified heat shock protein 
Hsp60 as another potential mimic which would add stress to the list of 
factors potentially involved. Although there is an association with 
several potential mimics and associated agents, it has not been 
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possible to show a direct establishment of an autoimmune disease in 
the thyroid with any agent. Indeed, induced animal models (McLachlan 
and Rapoport, 2014) from agents are common (see for instance: Mori 
and Yoshida, 2010 and Tomasi et al., 2005) – but most, except in 
genetically susceptible individuals (ElRehewy et al., 1981), require an 
adjuvant as part of the induction process. This can be an important 
hint if one looks for what could provide an adjuvant-like signal in 
addition to a mimic. In some sense, how the systems get to the point 
at which an autoimmune state eventually results may be more 
important to determine than which potential triggers could provide the 
initiation (the final step in a chain of steps). There may be many 
possible triggers, but unless the system can respond to them and 
initiate breaking of tolerance, there is no autoimmune disease. 
In this paper, we focus on the foundation that makes possible 
AITDs. The hint that this is the fundamental place to begin is in the 
large sex difference in the disease. Why women are so much more 
likely to develop AITDs has been difficult to establish. The reason for 
the sex difference has been examined from many angles, including 
genetics related to the X chromosome, pregnancy, and hormones (Lleo 
et al., 2008 and Fortunato et al., 2014), but none have been able to 
conclusively determine the cause except in genetically rare cases 
(McLachlan and Rapoport, 2014). Also, miRNA expression has been 
seen to show sex differences, providing yet another potential avenue 
for sex differences (reviewed in Dai and Ahmed (2014)). Associations 
between AITDs and type 2 diabetes (Coller and Huggins, 
1927 and Procaccini et al., 2011) and suggestions that inflammation 
may be at the core of both and responsible for the sex differences in 
incidence (Thorand et al., 2007). 
The sex differences in thyroid autoimmunity emerge at puberty. 
It has been noted (Whitacre, 2001) that at puberty, both leptin and 
estrogen rise in tandem. Both leptin (Procaccini et al., 2012) and 
estrogen (Cutolo et al., 1995) are potent modulators of the immune 
response. Leptin has also been suggested as being involved in some 
way in the sex differences in incidence of these diseases (Cojocaru et 
al., 2013). 
Here, we will try to establish an inflammatory cause for the 
development of the foundation for thyroid autoimmunity through leptin 
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and other adipokines (Carbone et al., 2012), and the ability of thyroid 
cells to participate in innate immunity (reviewed in Kawashima et al. 
(2011)). The thyroid also seems to be somewhat unique 
immunologically. The primary reason for this sensitivity seems due to 
the presence of lymphoid tissue akin to secondary lymphoid follicles 
with germinal centers in the thyroid autoimmunity (Armengol et al., 
2001). It is expected that this event happens early in the process after 
nonspecific responses result in increased lymphocyte infiltration into 
the thyroid (Armengol et al., 2003). A second aspect that makes the 
thyroid unique among autoimmune target tissues is that it is the only 
one with a hormone (TSH) that stimulates its growth (and increased 
thyroid antigens). In addition, CD40 expression in thyrocytes – at least 
those that are stressed in some way – allows the thyrocytes to 
function as antigen presenting cells. This aspect is implicated for 
Graves׳ disease. In Hashimoto׳s the specificity may be also through the 
link with CD20 B cells which are both implicated in diabetes initiation 
and necessary for the production of spontaneous autoimmune 
thyroiditis in mice. B-cell depletion also seems to result in the 
production of increased Treg cells (and lower levels of autoimmunity in 
mice). So, the unique nature appears to be both structural and the 
special nature of thyroid antigens and markers. 
Discovered in 1994 (Zhang et al., 1994), leptin is one of several 
proteins produced in adipose tissue (known as adipokines) that are 
believed to play a role in regulating energy intake and energy 
expenditure. As such, an association with the thyroid would not be 
unexpected. Recent results, however, point to a role for leptin both as 
an immune modulator and as a player in the initiation of autoimmune 
thyroid disease (Duntas and Biondi, 2013). The nature of the 
inflammation seen with leptin׳s influence (Fantuzzi, 2005), the sex 
differences in leptin levels (Hickey et al., 1996), innate immunity in 
the thyroid (using the Toll-like and other receptors), along with the sex 
differences in the nature of the immune response (Bouman et al., 
2005), provide solid testable hypotheses for the observed sex 
differences in AITDs. It should be noted that recent results on an X-
linked Toll-like receptor is claimed to determine sex differences in 
systemic lupus erythematosus (Umiker et al., 2014). 
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2. The thyroid and primary antigens associated 
with thyroid autoimmunity 
The thyroid has the primary task of producing two hormones, 
triiodothyronine (T3) and thyroxine (T4), that are responsible for the 
regulation of the metabolism of proteins, carbohydrates and fats. Also 
produced are calcitonin and small quantities of neuroendocrine 
peptides. The hormones T3 and T4 (especially the active T3) affect 
every cell in the body through regulation of oxygen consumption and 
metabolism, but they directly and indirectly affect other systems 
including the maintenance of homeostasis in blood pressure, digestion, 
and reproduction. The control of the production of the thyroid 
hormones is through a feedback system involving two hormones in the 
brain and receptors in the thyroid. The primary driver of hormone 
production is TSH (thyroid stimulating hormone or thyrotropin) 
produced by the pituitary. TSH receptors, found primarily on thyroid 
epithelial cells, bind TSH, beginning the cascade leading to thyroid 
hormone production. The production of TSH is controlled by the 
hormone TRH produced in the hypothalamus. The control of thyroid 
hormone production is described as involving this HPT (hypothalamus–
pituitary–thyroid) axis. 
Several anti-thyroid antibody in AITDs have been identified. For 
the purpose of diagnosis, antibody is primarily aimed at thyroglobulin 
(Tg), the prohormone of T3 and T4, thyroid peroxidase (TPO), the 
enzyme responsible for adding iodine to Tg, and the TSH receptor 
(TSHR). Antibody to any of these three primary antigens are 
diagnostic for AITDs. For Graves׳, antibody to TSHR causes an agnostic 
signal to continue production of thyroid hormone with disturbing the 
normal feedback control. In Hashimoto׳s thyroiditis, the primary anti-
thyroid antibody is against TPO. The rise of antibodies to TPO have 
been suggested to predict an eventual development of clinical disease 
(Hutfless et al., 2011). The direct damage through the antibody-
related complement system and antibody-dependent cellular 
cytotoxicity are not thought to be the primary cause of damage to the 
thyroid characteristic in the disease, however. Hashimoto׳s thyroiditis 
involves a complicated infiltration and interaction of immune and 
thyroid cells (reviewed in Iwona (2011)). Anti-Tg can be found in 
either condition, so is not diagnostic – except for the presence of an 
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autoimmune disease (Acar et al., 2013 and McLachlan and Rapoport, 
2013). A connection among TPO, TPO antibody, and breast cancer 
prognosis has been proposed (Muller et al., 2014). A mathematical 
description of the clinical progression of Hashimoto׳s thyroiditis can be 
found in Pandiyan et al. (2013). 
3. Inflammation, leptin, and diabetes 
The product of the ob gene, leptin, was discovered in 1994 
( Zhang et al., 1994). It was identified as a hormone involved in 
appetite control through the leptin receptor. Leptin, produced in white 
adipose tissue, affects appetite through a negative feedback loop 
involving the leptin receptor in the hypothalamus (reviewed in Arora 
and Arora (2008)). It is now known that leptin is one of a number of 
hormones, the adipokines, which have many functions – most having 
some impact on the thyroid (Cinar and Gurlek, 2013). One effect is 
both to alter thyroid function through disruption of the feedback loop 
of the HPT axis by altering TRH (Duntas and Biondi, 2013). A second 
effect is through inflammation and inflammatory molecules. The direct 
effect on the thyroid by inflammatory molecules (primarily TNF-α) can 
be seen in two studies: Zaccone et al. (2003) and Chen et al. (2007). 
In each, the role of the cytokine in generating autoimmune thyroid 
disease in the mouse is highlighted. In Zaccone et al., the role of the 
adjuvant is also described – similar to the steps suggested in this 
paper. 
In this paper, “leptin” will be used as referring to all of the 
adipokines in this context, which include leptin, adiponectin, TNF-α, 
and IL-6. The discovery that leptin is involved in low-level 
inflammation, provides both a marker of adipose tissue that can be 
measured, and a source of the inflammation is reviewed in Scotece et 
al. (2014). 
Leptin plasma levels correlated positively with body fat (Ostlund 
et al., 1996), but the relationship with sex is important for this study. 
Hickey et al. (1996) found that fasting serum leptin levels were over 
twice as high for females as males. This, along with possible effects of 
sex hormones, suggests that females should have more possibility of 
low-level chronic inflammation complications than men (Bouman et al., 
2005 and Casimir et al., 2010). It should be noted that the study by 
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Casimir et al. was completed on children before the effects of 
hormones would be expected. The potential suppressive effect of 
testosterone also suggests this result (Furman et al., 2014). The 
human data on this connection is limited, however. One recent study 
by Harpsøe et al. (2014) has identified an association between Body 
Mass Index (BMI) (an indirect measure of serum leptin levels), and 
several autoimmune diseases. Marzullo et al. (2010) have established 
that leptin levels are correlated with thyroid autoimmunity 
independent of bioanthromorphic, hormonal, or weight-related 
measures. 
The interplay between thyroid disease and leptin in development 
of diabetes is complicated by several interacting systems (Hage et al., 
2011). In terms of inflammation and thyroid, metabolic syndrome is 
clearly associated, for instance see Shantha et al. (2009) and Ruhla et 
al. (2010). The transition from metabolic syndrome to type 2 diabetes 
is a well-known risk. A fraction (about 10%) of these type 2 or 
metabolic syndrome is eventually recognized as Latent Autoimmune 
Diabetes in Adults (Unger, 2007), an autoimmune disease associated 
(as is type 1 diabetes) with thyroid autoimmunity (Koch, 2011). 
4. Innate immunity and the pattern recognition 
receptors (PRR) in the thyroid 
Besides the role of leptin in providing a signal which triggers 
inflammation and affecting the HPT axis, the native thyroid cells, 
thyrocytes, also play a role in the innate immune system. Thyrocytes 
have the ability to recognize and respond to pathogen-associated 
molecular patterns (PAMP) through PRR. The PRR׳s include Toll-like 
receptors, Nod-like receptors and many others (reviewed in 
Kawashima et al. (2011)). Thyrocytes also have the ability to respond 
to damage-associated molecular patterns (DAMP) coming from cellular 
damage (Kawashima et al., 2011) – especially a response to double 
stranded DNA and/or RNA. The response of thyrocytes to these 
patterns plays two roles in this setting. One is to further increase the 
presence of inflammatory cytokines, TNF-α, IL-1, and IL-6, to promote 
a specific immune response. Toll-like receptors have been described as 
adjuvant receptors (Kaisho and Akira, 2002). The second is the 
presentation of self-antigens in association with MHCII expression on 
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thyroid cells (Kawashima et al., 2013). Inflammatory molecules have 
been recognized with a breaking of tolerance in the context of thyroid 
autoimmunity with a like-self (or self) antigen (Akeno et al., 2011). 
The identified mimics now have the stage set to overcome self-
tolerance. Note that if mimics are presented in the system in most 
animal models without an adjuvant signal, they are not able to 
generate autoimmunity. 
Another aspect of this response may be in response to stress, 
where heat shock protein Hsp60, triggered as a response to the 
stresses of many conditions, is a mimic. In addition, the stress 
disruption of the Hypothalamic–Pituitary–Adrenal (HPA) axis is also 
seen to play a role in the altering of the immune response 
characteristics (Klecha et al., 2008). 
5. Multiple autoimmune syndrome and 
autoimmune polyglandular syndrome 
One hint as to the relationship between the various autoimmune 
disorders useful here is through the idea of Multiple Autoimmune 
Syndrome (MAS) described by Humbert and Dupond (1988). MAS is 
the coexistence of 3 or more autoimmune disorders in one individual. 
The useful grouping of autoimmune disorders of those that tend to be 
present together if they are present is useful in this discussion 
(Cojocaru et al., 2010). 
 Type 1 MAS includes myasthenia gravis, thyoma, polymyositis, 
and giant cell myocarditis. 
 Type 2 MAS includes Sjögrens׳s syndrome, rheumatoid arthritis, 
primary cirrhosis, sclerodema, and autoimmune thyroid disease. 
 Type 3 MAS includes autoimmune thyroid disease, myasthenia 
gravis and/or thyoma, Sjögrens׳s syndrome, pernicious anemia, 
idiopathic thrombopenic purpura, Addison׳s disease, type 1 
diabetes mellitus, vitiligo, SLE, and several others. 
Cojocaru et al. (2010) note that in the medical literature, a 
dermatological disease, usually vitiligo, is first to be diagnosed, but in 
most cases, autoimmune thyroid disease was also present (Ai et al., 
2003). Although diagnosis of the syndrome indicates some genetic or 
environmental pre-disposition for autoimmunity, it does suggest that 
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in Type 2 and Type 3, that if an autoimmune condition is present, it is 
likely that autoimmune thyroid disease is also present – and was likely 
present at the time of diagnosis. 
It is likely that Type 2 MAS and Type 3 MAS are those 
autoimmune diseases where inflammation similar to that in AITD plays 
a role. It should be noted that in several autoimmune disorders, e.g. 
autoimmune hemolytic anemia and autoimmune thrombocytopenia, do 
not seem to require inflammation, although they can be associated 
with other autoimmune conditions that do. Also, certainly, 
inflammation does not always cause autoimmune disease. 
A similar view of the relationship between autoimmune 
disorders is through autoimmune polyglandular syndrome where AITD 
is considered “Type 2” (Betterle et al., 2004). Type 2 APS is defined by 
the occurrence of Addison׳s disease with thyroid autoimmune disease 
and/or Type 1 diabetes mellitus. There is some evidence (Krysiak et 
al., 2014) that treatment with anti-inflammatory agents may be a 
useful treatment in Type 2 APS. 
6. Discussion 
The leptin levels rise in young girls as they approach puberty 
while in boys, leptin declines along with testosterone increase (Garcia-
Mayor et al., 1997). This increase begins a life-long dance between 
leptin and low-grade inflammation. Leptin׳s inflammatory effects are 
first felt in fat and liver (Li et al., 2006). In the thyroid context, leptin 
disrupts the HPT axis controlling thyroid function. Leptin also interferes 
with other systems as well. But unlike other systems, the interaction 
between thyroid disruption/weight gain and adipose tissue 
production/leptin production is unique to the thyroid. Many organs feel 
the inflammatory effects of leptin, but the disruption of control along 
with the inflammation is likely a unique condition. The dance continues 
in postmenopausal women as described by Teixeira et al. (2009) 
where serum leptin is elevated in postmenopausal women with 
subclinical or overt hyperthyroidism. IL-6 is also seen as elevated in 
this population (Siemińska et al., 2010). As events and pathogens that 
trigger the PAMP and DAMP response of the thyrocytes over time, the 
situation in the thyroid can be ripe for an autoimmune trigger. In men, 
with the level of underlying leptin-caused inflammation lower (due to 
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leptin and suppressed by testosterone), the thyroid is not in a state 
that is as conducive to autoimmunity. An additional factor, not 
discussed here, is the relationship between pregnancy and the 
triggering of thyroid disruption and autoimmunity – primarily Graves׳ 
disease (Carney et al., 2014). A further step to the breaking of 
tolerance allowing the establishment of an autoimmune disease is 
further facilitated by the effect of leptin on regulatory T (Treg cells) 
(Matarese et al., 2010), where the Treg numbers are seen to be 
inversely correlated with serum leptin. 
The specificity of the thyroid to the immune response seems due 
to the presence of lymphoid tissue akin to secondary lymphoid follicles 
with germinal centers in the thyroid autoimmunity (Armengol et al., 
2001). It is expected that this event happens early in the process after 
nonspecific responses result in increased lymphocyte infiltration into 
the thyroid (Armengol et al., 2003). A second aspect that makes the 
thyroid unique among autoimmune target tissues is that it is the only 
one with a hormone (TSH) that stimulates its growth (and increased 
thyroid antigens). In addition, CD40 expression in thyrocytes – at least 
those that are stressed in some way – allows the thyrocytes to 
function as antigen presenting cells. This aspect is implicated for 
Graves׳ disease. In Hashimoto׳s the specificity may be also through the 
link with CD20 B cells which are both implicated in diabetes initiation 
and necessary for the production of spontaneous autoimmune 
thyroiditis in mice. B-cell depletion also seems to result in the 
production of increased Treg cells (and lower levels of autoimmunity in 
mice). So, the nature appears to be both structural and the special 
nature of thyroid antigens and markers. 
Over time, the thyroid provides an adjuvant-like setting if 
specific mimic or self-antigens are present, resulting in autoimmunity 
in the thyroid. It is at this time that the molecular mimics described in 
the Introduction play a role. The fact that the specific agent or agents 
present at the overcoming of tolerance indicate why it has been 
difficult to identify a specific one in this case. The nature of this 
response will be determined by the agents which triggered the 
response and indicated by the anti-thyroid antibodies produced. This 
process is summarized in Fig. 1. 
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Fig. 1. Diagram of the hypothesized process by which thyroid autoimmunity is 
created. 
7. Conclusion 
The triggers of AITDs discussed contribute to the disease in 
many ways with different weights and relative importance. They cause 
the hormone deregulation and ultimately result in clinical malfunction 
of thyroid. The regulation and physiological responsiveness of the 
thyroid are also influenced by many factors, the susceptibility of 
thyroid to autoimmunity due to the unique regulation system and 
response axis to maintain delicate homeostasis and the structural 
integrity. The humoral and cellular immunity are dynamic and 
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autoimmunity can also be influenced by a multitude of factors. In 
certain circumstances, the predominant status can be fragile, 
influenced by one factor which overwhelms the others – affecting the 
overall autoimmune balance. Throughout the inflammatory progress 
and/or persistent stimulation, secondary autoimmune disorders in 
distal relatively resistant organs, such as pancreas, rheumatoid 
arthritis, etc. may be seen as starting with a thyroid 
malfunction/disorder. 
With many mimics and factors, it would seem that the initiation 
of AITDs is very complicated – but at its heart, it may very well be a 
natural result of inflammation caused by leptin, and the presence of a 
trigger through PAMP or DAMP, along with a mimic or cell damage. The 
increased incidence in females can be easily seen in this context 
through increased leptin. There can be other aspects, suppression 
through testosterone in men, and the specifics of a stress response 
further shape a complete picture. In individuals with several 
autoimmune diseases, it is likely that thyroid autoimmunity also exists 
(and likely was existing at the time of the first diagnosis). 
With the stage set by 1) inflammation, 2) the ability of the 
thyrocytes to respond to patterns, 3) a large collection of mimics and 
other agents, and 4) disruption of thyroid and Treg function (and 
resulting feedback to adipose tissue), the stage is set for AITDs. And, 
a process that results in an increased incidence of AITDs in females. 
7.1. Testable hypotheses 
Several aspects of this theory are directly testable. Some of the 
most critical are listed here. 
1) Central to the hypothesis is that inflammation due to leptin is a 
contributing agent to the development of AITD. Since there is an 
increase in obesity in the US, there should be a shift in the 
development of AITD to younger populations. There is a partial 
test of this idea in Popławska-Kita et al. (2014) where the Body 
Mass Index (BMI) was examined in Hashimoto׳s thyroiditis 
patients, both in euthyroid (normal T4 levels) and hypothyroid 
conditions. It was found that Hashimoto׳s patients had higher 
BMI and fat mass than controls. This is not quite a test as 
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disruption of the thyroid hormone can result in weight gain. But 
note that the result hold for euthyroid patients as well. 
2) The rate of Hashimoto׳s in men should increase along with 
increasing obesity. This may involve a description of the level of 
obesity needed to generate an increase in the disease. 
3) One should find the presence of high concentration of adipokine 
inflammatory molecules as predictive for the development of 
AITD. This has been explored by Mikoś et al. (2014) who found 
that in children, levels of IL-1β, TNF-α, and IL-6 are predictive 
of AITD and the level of IL-1β can be specifically used to 
distinguish Hashimoto׳s from Graves׳ disease. This was done in 
normal and diagnosed (but not treated) children, so it is not a 
predictive test. 
4) Patients who develop Hashimoto׳s over time subclinical 
hypothyroidism should show inflammatory differences, or 
differences in BMI from those who do not. 
Both obesity and Hashimoto׳s increase post-menopause, but is 
Hashimoto׳s caused by obesity (i.e., leptin increasing)? There should 
be an easy proof that is likely an epidemiology study not yet 
completed. With dramatically increasing obesity rates in the US there 
should be a “shift” in Hashimoto׳s from occurring almost exclusively 
post-menopause to occurring earlier in life (excluding Graves׳ disease 
which occurs by a different mechanism/Ab-mediated receptor 
activation). If leptin is critically important then there should also be a 
“shift” to more men developing Hashimoto׳s since obesity is also 
increasing for males. 
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